Literature DB >> 2017262

Chemical synthesis of glycosaminoglycans: new approaches to antithrombotic drugs.

M Petitou1, J C Lormeau, J Choay.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2017262     DOI: 10.1038/350030a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

Review 1.  New anticoagulants: anti IIa vs anti Xa--is one better?

Authors:  Kenneth A Bauer
Journal:  J Thromb Thrombolysis       Date:  2006-02       Impact factor: 2.300

2.  Effects of glycosaminoglycans on proliferation of epithelial and fibroblast human malignant mesothelioma cells: a structure-function relationship.

Authors:  A Syrokou; G Tzanakakis; T Tsegenidis; A Hjerpe; N K Karamanos
Journal:  Cell Prolif       Date:  1999 Apr-Jun       Impact factor: 6.831

3.  Low allergenic potential with fondaparinux: results of a prospective investigation.

Authors:  Marc Schindewolf; Julia Scheuermann; Hartmut Kroll; Jurate Garbaraviciene; Carola Hecking; Ingo Marzi; Manfred Wolter; Roland Kaufmann; Wolf-Henning Boehncke; Edelgard Lindhoff-Last; Ralf J Ludwig
Journal:  Mayo Clin Proc       Date:  2010-09-15       Impact factor: 7.616

4.  De novo synthesis of a narrow size distribution low-molecular-weight heparin.

Authors:  Kasemsiri Chandarajoti; Yongmei Xu; Erica Sparkenbaugh; Nigel S Key; Rafal Pawlinski; Jian Liu
Journal:  Glycobiology       Date:  2014-03-13       Impact factor: 4.313

5.  Characterization of heparin oligosaccharides binding specifically to antithrombin III using mass spectrometry.

Authors:  Hicham Naimy; Nancy Leymarie; Michael J Bowman; Joseph Zaia
Journal:  Biochemistry       Date:  2008-02-09       Impact factor: 3.162

6.  Computationally derived points of fragility of a human cascade are consistent with current therapeutic strategies.

Authors:  Deyan Luan; Michael Zai; Jeffrey D Varner
Journal:  PLoS Comput Biol       Date:  2007-07       Impact factor: 4.475

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.